AUSTIN, TEXAS — Shokz has announced that its OpenHear BM420 bone conduction hearing aid has been named a CES 2027 Innovation Awards Honoree in the Accessibility & Longevity category. Developed by ShokzHear, an affiliated professional hearing-care company of Shokz, the device represents an expansion of the company’s established open-ear audio technology into professionally fitted hearing solutions.
The OpenHear BM420 is a non-surgical bone conduction hearing aid designed to provide an alternative for eligible individuals who may benefit from hearing assistance without having a device positioned inside the ear canal. The product combines personalized hearing settings, directional microphones, environmental noise reduction, and audio streaming capabilities.
The recognition comes ahead of the device’s planned U.S. availability on November 20, 2026, through participating hearing centers, ear, nose, and throat (ENT) clinics, and hospitals.
Bringing Open-Ear Technology into Professional Hearing Care
Shokz is widely known for its consumer bone conduction headphones, which transmit sound through vibrations while leaving the ear canal unobstructed. Through ShokzHear, the company is applying its experience with this technology to hearing devices intended for people with hearing loss.

Unlike conventional air conduction hearing aids, which deliver amplified sound through the ear canal, bone conduction devices transmit mechanical vibrations through the skull to stimulate the cochlea.
Bone conduction technology has long been used in hearing healthcare, particularly for patients with conductive or mixed hearing loss and certain other clinical indications. Solutions range from externally worn devices to surgically implanted bone conduction systems.
The OpenHear BM420 takes a non-surgical approach, using an open-ear design that avoids placing components inside the ear canal. According to ShokzHear, this configuration is intended to support comfort during extended wear while providing hearing assistance tailored to the individual.
The official CES product listing describes the BM420 as designed for individuals with conductive, mixed, or sensorineural hearing loss. However, the suitability of bone conduction amplification depends on the individual’s audiometric characteristics and clinical needs.
Personalized Fitting and Everyday Listening Features
The OpenHear BM420 incorporates several features commonly associated with modern hearing technology, including individually adjustable hearing settings and directional microphones intended to improve speech understanding in challenging environments.
According to the manufacturer, its key capabilities include:
- Personalized professional fitting: Hearing settings can be adjusted to address individual listening needs.
- Open-ear design: The ear canal remains unobstructed, potentially benefiting users who find conventional in-ear devices uncomfortable.
- Directional microphones: Designed to emphasize sounds coming from particular directions.
- Environmental noise reduction: Intended to reduce competing background sounds during everyday listening.
- Audio streaming: Provides additional functionality beyond hearing assistance, including listening to streamed audio.
The company also emphasizes the device’s intuitive controls and ease of wear, particularly for older adults and individuals seeking a more accessible hearing solution.
Recognition at CES 2027
The CES Innovation Awards program, organized by the Consumer Technology Association (CTA), recognizes products demonstrating notable design and engineering across consumer technology categories.
The OpenHear BM420 was selected as a 2027 honoree in the Accessibility & Longevity category, which highlights technologies intended to improve accessibility and support everyday living.
“In hearing care, performance matters, but so does whether people feel comfortable wearing a device day after day,” said Fengyun Liao, director of ShokzHear, in the company’s announcement. “OpenHear BM420 brings our experience in open-ear bone conduction technology to that challenge, offering an alternative designed around both hearing assistance and everyday comfort. We’re honored to have this approach recognized by the CES Innovation Awards.”
The CES Innovation Awards recognize product design and engineering, with entries evaluated based on materials submitted by participating companies.
U.S. Availability and Outlook
ShokzHear plans to make the OpenHear BM420 available in the United States beginning November 20, 2026, through participating hearing centers, ENT clinics, and hospitals.
The company’s move into professional hearing care reflects broader interest in expanding the range of hearing technologies available to people with hearing loss, particularly solutions that offer different wearing styles and approaches to sound delivery.
For hearing care professionals, the BM420 introduces another potential non-surgical bone conduction option to consider when evaluating patient needs and preferences. Its clinical role will depend on fitting indications, audiological performance, patient comfort, and outcomes in everyday listening environments.
Shokz is also expected to showcase its expanding open-ear technology portfolio at CES 2027, scheduled for January 6–9 in Las Vegas.
Additional information is available through ShokzHear.
Source: Shokz







